Skip to content

The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series

The Use of LMA-Proseal and Endobronchial Blocker for One Lung Anesthesia, Case Series.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02106273
Enrollment
29
Registered
2014-04-08
Start date
2011-04-30
Completion date
2013-09-30
Last updated
2014-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthetic Technique, One-lung Ventilation

Keywords

LMA, Bronchial blocker

Brief summary

An observational pilot study to determine the success rate of using LMA Proseal in conjuction with endobronchial blocker to provide one-lung anesthesia for thoracic surgery.

Detailed description

The use of LMA has gained popularity secondary to benefits confirmed by many literatures. However, LMA is rarely used in thoracic surgery. To enable one-lung ventilation, the LMA need to be used with bronchial blocker. The use of this combination has been reported as a rescue technique in special clinical scenarios, i.e. patient with difficult airway. When used in patient with difficult airway, the LMA will be inserted until proper ventilation achieved, then endobronchial blocker will be subsequently placed through the LMA into the selected main bronchus. The success rate of the the bronchial blocker placement via properly placed LMA has never been studied. This pilot study was designed to evaluate the success rate, the quality of lung collapsed, the dislodgement or other associated problems including some minor complications i.e. postoperative dysphagia, sore throat hoarseness of voice.

Interventions

DEVICEBronchial blocker (Coopdech, Arndt)

Using bronchial blocker with LMA

DEVICELMA-ProsealTM

Sponsors

Mahidol University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* thoracic surgery that needed one-lung ventilation

Exclusion criteria

patient with * Restrictive lung disease that needed positive pressure ventilation \> 30 cm.H2O * Mass or hematoma in the mouth which obstruct LMA insertion * Emergency surgery * Pregnancy * Severe infection or active pulmaonary tuberculosis * Hemoptysis * Pulmonary nodule \> 20 cm. or bronchilal pathology * Pneumonectomy or sleeve resection

Design outcomes

Primary

MeasureTime frameDescription
success rate15 mintuescan provide one-lung ventilation within 15 mintues

Secondary

MeasureTime frameDescription
Time consuming in achieving one-lung anesthesia15 mintuesTotal time spent to place bronchial blocker into the selected main bronchus shall not exceed 15 minutes. If investigators failed, the study will be terminated and patient will receive appropriate conventional airway management.
Sorethroat1 dayPatient self assessment scale as followed 0 - no sore throat 1. \- mild sore throat (no pain at rest, only with swallowing, does not require intervention) 2. \- moderate sore throat (some discomfort at rest, more with swallowing - but does not need medications) 3. \- severe sore throat (at rest, require analgesics for sore throat)
Hoarseness of voice1 dayPatient assessment scale by visitor as followed 0 - no hoarseness of voice detected, normal voice. 1. \- some hoarseness of voice detected but able to speak in all octaves. 2. \- notable hoarseness of voice, unable to phonate in high pitch. 3. \- marked hoarseness of voice, unable to phonate
Difficulty swallowing1 dayPatient self assessment and visitor assessment in scale as followed. 0 - no problem swallowing. no pain. 1. \- some sore throat (grade 1) with swallowing but able to swallowing both liquid and solid. 2. \- moderate swallowing limitation, only liquid or soft diet swallowing - unable to swallow solid food 3. \- marked swallowing limitation, patient prefers to fast due to pain associated with swallowing. Speech therapist/OT/PT consult to evaluation swallowing problems

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026